Sign in
TerminatedNo phase

Stress and Neurofeedback in Anorexia Nervosa

Key facts

Who runs it
University of California, San Diego
Where
San Diego, United StatesSee the site
Trial code
Status
Terminated
People taking part
2 people enrolled
Started
26 Apr 2023
Ended
25 Mar 2025
Type of study
Interventional
Treatments tested
  • Negative Affect Task
Record updated
30 March 2025
Why it stopped
No funding received

Who can take part

Age
18 years to 45 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 45 criteriaShow less

Who can take part

  • Healthy Controls (HC)
  • Individuals aged 18-45 years
  • Healthy body weight between 90 and 110 % average body weight since puberty
  • Regular monthly menstrual cycle (if applicable)
  • Edinburgh Handedness Inventory Revised (EHI-R) LQ* score > +200
  • All ethnic backgrounds
  • English is primary language spoken; Anorexia Nervosa (AN)
  • Age 18-45 years old
  • Edinburgh Handedness Inventory Revised (EHI-R) LQ* score > +200
  • All ethnic backgrounds
  • Current diagnosis of anorexia nervosa, including being underweight, will have a severe fear of weight gain, body image distortion and absence of the menstrual cycle over three consecutive months
  • English is primary language spoken; Atypical Anorexia Nervosa (AAN)
  • Age 18-45 years old
  • Edinburgh Handedness Inventory Revised (EHI-R) LQ* score > +200
  • All ethnic backgrounds
  • Meets the criteria for anorexia nervosa except despite significant weight loss, the individual's weight is within or above the normal range
  • English is primary language spoken

Who cannot take part

  • Contraindications to magnetic resonance imaging (MRI) including metal implants or braces (as determined through fMRI screening form); Anorexia Nervosa (AN)
  • Contraindications to MRI including metal implants or braces (as determined through fMRI screening form); Atypical Anorexia Nervosa (AAN)
  • Contraindications to MRI including metal implants or braces (as determined through fMRI screening form)
  • First degree relative with current or past eating disorder
  • Psychiatric Medication use such as selective serotonin reuptake inhibitors (SSRIs), atypical antipsychotics, etc
  • Past or present Axis I psychiatric disorder including substance or alcohol use disorder as determined through structured clinical interview
  • History of significant head trauma
  • Indication of intellectual disability or autism spectrum disorder
  • Major Medical illness that requires medication or have significant impact on subject's life such as: diabetes, Alzheimer's disease or dementia, stroke, learning disability, mobility disorders, cancer, high blood pressure, etc. (to be determined through biological screening form and interview with principal investigator (PI)
  • Recent history of suspected substance abuse or a lifetime history of psychostimulant abuse and/or dependence
  • Lifetime history of bipolar I disorder or psychosis
  • Psychotic illness/other organic brain syndromes, dementia, somatization disorders or conversion disorders
  • Physical conditions (e.g., diabetes mellitus, pregnancy) known to influence eating or weight
  • History of significant head trauma
  • Indication of intellectual disability or autism spectrum disorder
  • Lifetime history of bipolar disorder or psychosis
  • Psychotic illness/other organic brain syndromes, dementia, somatization disorders or conversion disorders
  • Physical conditions (e.g., diabetes mellitus, pregnancy) known to influence eating or weight
  • History of significant head trauma
  • Indication of intellectual disability or autism spectrum disorder
  • Electrolyte, blood count or kidney or liver function abnormalities
  • Electrolyte, blood count or kidney or liver function abnormalities
  • Healthy Controls (HC)
  • Current pregnancy or breast feeding within last 3 months
  • Pregnancy or breast feeding within last 3 months
  • Current substance abuse or dependence in the past 3 months
  • Pregnancy or breast feeding within last 3 months
  • Current substance abuse or dependence in the past 3 months

Where in United States

  • University of California San DiegoSan Diego, United States

About the trial

What the trial wants to find out

Anorexia nervosa (AN) and atypical AN (AAN) are severe psychiatric illnesses associated with high disease burden including high treatment costs and excessive mortality rates. Primary characteristics of AN and AAN are food restriction, associated fear of weight gain, and a disturbance in how one's body weight or shape is experienced.The underlying neural mechanisms for the core illness behaviors of food restriction and body size overestimation in anorexia nervosa and atypical anorexia nervosa are not well understood.

Read full original descriptionShow less

This project will use neurofeedback and advanced psychophysical methods to assess and moderate the neural and behavioral responses to stress and relate those results to the naturalistic environment. The results will guide the development of novel interventions.

The group in the trial

  • BehavioralTreatment being tested

    Negative Affect Task

    Treatment: Negative Affect Task

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Neural Mechanisms of Negative Affect and Neurofeedback in Anorexia Nervosa
Record updated
30 March 2025